Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 18 of 18

List	Outcome	Time frame	Description
Primary	Changes in food intake at ad libitum meal	6 months	Changes in food intake at ad libitum meal measured at each experimental day
Primary	Satiety	6 months	Satiety measured on a visual analog score 13 times during each experimental day.
Secondary	Changes in lean mass assessed through lean mass	6 months	Changes in lean mass assessed through lean mass with DEXA-scan
Secondary	Changes in fat mass assessed through lean mass with DEXA-scan	6 months	Changes in lean mass assessed through lean mass with DEXA-scan
Secondary	Changes in gall bladder emptying	6 months	Changes in gall bladder emptying evaluated with ultrasound 6 times each experimental day before and after meal.
Secondary	Changes in resting energy expenditure	6 months	Changes in resting energy expenditure measured 3 times each experimental day using Indirect Calorimetry.
Secondary	Changes in blood sugar response to standardized meal.	6 Months	changes in blood sugar response to standardized meal measured before and after meal at each experimental day.
Secondary	Changes in stomach emptying	6 months	Evaluated with continously measuring serum paracetamol after standardized meal containing 1,5 g paracetamol.
Secondary	Changes in GIP hormones	6 months	Continously measuring of a range of hormones during each experimental day: GIP
Secondary	Changes in GLP-1 hormones	6 months	Continously measuring of GLP-1 hormones during each experimental day
Secondary	Changes in GLP-2 hormones	6 Months	Continuously measuring of GLP-2 hormones during each experimental day
Secondary	Changes in PYY hormones	6 Months	Continuously measuring of PYY hormones during each experimental day
Secondary	Changes in CCK hormones	6 Months	Continuously measuring of CCK hormones during each experimental day
Secondary	Changes in Gastrin hormones	6 Months	Continuously measuring of Gastrin during each experimental day
Secondary	Changes in Insulin hormones	6 Months	Continuously measuring of Insulin during each experimental day
Secondary	Changes in Glucagon	6 Months	Continuously measuring of Glucagon during each experimental day
Secondary	Changes in C-peptide	6 Months	Continuously measuring of C-peptide during each experimental day
Secondary	Changes in Free-Fatty acids	6 Months	Continuously measuring of Free Fatty acids during each experimental day

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02993562/registered

API reference For AI assistants